Search research articles
Contact Us
Filters
Showing results (71-80 of 138) with videos related to
Page
of 14
Sort By:
European Journal of Haematology
|
April 4, 2012
Multiple myeloma in octogenarians: clinical features and outcome in the novel agent era
Meletios A Dimopoulos, Efstathios Kastritis, Sossana Delimpasi, et al.
Blood
|
March 17, 2024
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee
Francesco Onida, Nico Gagelmann, Yves Chalandon, et al.
Pharmacogenomics
|
August 9, 2019
Genomic variants in members of the Krüppel-like factor gene family are associated with disease severity and hydroxyurea treatment efficacy in β-hemoglobinopathies patients
Apostolos Stratopoulos, Alexandra Kolliopoulou, Kariofyllis Karamperis, et al.
Annals of Hematology
|
March 17, 2019
Bone marrow PARP1 mRNA levels predict response to treatment with 5-azacytidine in patients with myelodysplastic syndrome
Panagiotis T Diamantopoulos, Christina-Nefeli Kontandreopoulou, Argiris Symeonidis, et al.
British Journal of Haematology
|
July 28, 2015
Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation
Argiris Symeonidis, Anja van Biezen, Liesbeth de Wreede, et al.
American Journal of Hematology
|
April 17, 2018
The prognostic value of monosomal karyotype (MK) in higher-risk patients with myelodysplastic syndromes treated with 5-Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group
Sotirios G Papageorgiou, Diamantina Vasilatou, Christos K Kontos, et al.
Blood Advances
|
September 7, 2021
Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists
Igor Stojkov, Annette Conrads-Frank, Ursula Rochau, et al.
American Journal of Hematology
|
June 21, 2023
Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study
Efstathios Kastritis, Evangelos Terpos, Argiris Symeonidis, et al.
Hematological Oncology
|
December 17, 2020
Upregulated hypoxia inducible factor 1α signaling pathway in high risk myelodysplastic syndrome and acute myeloid leukemia patients is associated with better response to 5-azacytidine-data from the Hellenic myelodysplastic syndrome study group
Vassiliki Mpakou, Aris Spathis, Anthi Bouchla, et al.
Leukemia Research
|
May 26, 2021
Subdiaphragmatic extranodal localizations at diagnosis of primary mediastinal large B-cell lymphoma: an impressive, rare presentation with no independent effect on prognosis
Stamatis Karakatsanis, , Sotirios G Papageorgiou, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 138) with videos related to
Sort By:
Page
of 14
European Journal of Haematology
|
April 4, 2012
Multiple myeloma in octogenarians: clinical features and outcome in the novel agent era
Meletios A Dimopoulos, Efstathios Kastritis, Sossana Delimpasi, et al.
Blood
|
March 17, 2024
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee
Francesco Onida, Nico Gagelmann, Yves Chalandon, et al.
Pharmacogenomics
|
August 9, 2019
Genomic variants in members of the Krüppel-like factor gene family are associated with disease severity and hydroxyurea treatment efficacy in β-hemoglobinopathies patients
Apostolos Stratopoulos, Alexandra Kolliopoulou, Kariofyllis Karamperis, et al.
Annals of Hematology
|
March 17, 2019
Bone marrow PARP1 mRNA levels predict response to treatment with 5-azacytidine in patients with myelodysplastic syndrome
Panagiotis T Diamantopoulos, Christina-Nefeli Kontandreopoulou, Argiris Symeonidis, et al.
British Journal of Haematology
|
July 28, 2015
Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation
Argiris Symeonidis, Anja van Biezen, Liesbeth de Wreede, et al.
American Journal of Hematology
|
April 17, 2018
The prognostic value of monosomal karyotype (MK) in higher-risk patients with myelodysplastic syndromes treated with 5-Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group
Sotirios G Papageorgiou, Diamantina Vasilatou, Christos K Kontos, et al.
Blood Advances
|
September 7, 2021
Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists
Igor Stojkov, Annette Conrads-Frank, Ursula Rochau, et al.
American Journal of Hematology
|
June 21, 2023
Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study
Efstathios Kastritis, Evangelos Terpos, Argiris Symeonidis, et al.
Hematological Oncology
|
December 17, 2020
Upregulated hypoxia inducible factor 1α signaling pathway in high risk myelodysplastic syndrome and acute myeloid leukemia patients is associated with better response to 5-azacytidine-data from the Hellenic myelodysplastic syndrome study group
Vassiliki Mpakou, Aris Spathis, Anthi Bouchla, et al.
Leukemia Research
|
May 26, 2021
Subdiaphragmatic extranodal localizations at diagnosis of primary mediastinal large B-cell lymphoma: an impressive, rare presentation with no independent effect on prognosis
Stamatis Karakatsanis, , Sotirios G Papageorgiou, et al.
Page
of 14